SCHEMBL25331392

SCHEMBL25331392

CC(C)(C)OC(=O)CCOCCOCCOCCOCCNC(=O)CCOCCOCCOCCOCCNC(=O)CCOCCOCCOCCOCCNC(=O)[C@H](NC(=O)OCc1ccccc1)[C@@H](NC(=O)OCc1ccccc1)C(=O)NCCOCCOCCOCCOCCC(=O)NCCOCCOCCOCCOCCC(=O)NCCOCCOCCOCCOCCC(=O)OC(C)(C)C

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ LMNA P02545 2/20 0.49
▸ SYK P43405 1/20 0.47
▸ CTSS P25774 4/20 0.45
▸ CTSL P07711 3/20 0.45
▸ CAPN1 P07384 1/20 0.44
▸ CAPN2 P17655 1/20 0.44
▸ CTSB P07858 2/20 0.44
▸ CA2 P00918 1/20 0.44
▸ CA5A P35218 1/20 0.44
▸ MAPT P10636 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ SIRT2 Q8IXJ6 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ CTSK P43235 2/20 0.41
▸ BCHE P06276 1/20 0.40
▸ ACHE P22303 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29467718 0.95 CAPN1 (0.47) SMN1; SMN2LMNASYKCTSSCTSL
SCHEMBL30407162 0.91 SMN1; SMN2 (0.47) SMN1; SMN2LMNASYKCTSSCTSL
SCHEMBL25330859 0.89 LMNA (0.63) SMN1; SMN2LMNASYKMAPTMEN1
SCHEMBL25195645 0.89 LMNA (0.63) SMN1; SMN2LMNASYKMAPTMEN1
SCHEMBL29548496 0.87 SMN1; SMN2 (0.47) SMN1; SMN2LMNASYKCTSSCTSL
SCHEMBL29467638 0.87 SMN1; SMN2 (0.47) SMN1; SMN2LMNASYKCTSSCTSL
SCHEMBL23451336 0.87 SMN1; SMN2 (0.52) SMN1; SMN2LMNASYKMAPTMEN1
SCHEMBL25372019 0.86 LMNA (0.62) SMN1; SMN2LMNASYKMAPTMEN1
SCHEMBL29467716 0.85 HTT (0.53) SMN1; SMN2LMNACTSSCTSLCAPN1
SCHEMBL24572425 0.85 SMN1; SMN2 (0.69) SMN1; SMN2LMNASYKMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230241241-A1 CONJUGATES OF A CELL-BINDING MOLECULE WITH CAMPTOTHECIN ANALOGS HANGZHOU DAC BIOTECH CO., LTD. (CN) 2023-08-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230241241-A1 CONJUGATES OF A CELL-BINDING MOLECULE WITH CAMPTOTHECIN ANALOGS CD4, DCLRE1A, TOP1 SMN1; SMN2 4335/4885LMNA 493/4885SYK 1271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback